GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

The researchers looked at how much weight the patients lost after 3, 6 and 12 months. People who took semaglutide lost, on ...